In a surprise twist, 23andMe founder and former CEO Anne Wojcicki is set to regain control of the DNA company's assets, according to a press release from 23andMe. In May, a company called Regeneron bought 23andMe for $256 million in a bankruptcy auction, but Wojcicki's nonprofit, TTAM Research Institute, was able to reopen bidding with an "unsolicited offer" of $305 million, The Wall Street Journal reports.<br /> A bankruptcy judge agreed to reopen bidding on 23andMe under the condition that Regeneron top Wojcicki's proposed price by at least $10 million, according to WSJ. Regeneron declined, leaving 23andMe in TTAM's control assuming the judge approves the deal. A hearing to consider the new deal is set for June 17, 2025.<br /> Regeneron had previ [...]
DNA testing company 23andMe has filed for Chapter 11 bankruptcy, following a tumultuous few years that included significant layoffs and a wide-ranging data breach. It plans to find a buyer and continu [...]
23andMe (ME) on Sunday filed for bankruptcy protection after struggling to combat weak demand for its DNA testing kit and the fallout of a data breach that effected millions of customers. Read more... [...]
Genetic testing company 23andMe (ME) filed for bankruptcy protection Sunday in the latest stage of a rocky road that included weak consumer demand and a 2023 data breach that jeopardized the genetic d [...]
Novo Nordisk is expanding its cash-only savings program offering its blockbuster weight-loss drug Wegovy for $499 a month at all U.S. pharmacies. 23andMe has filed for Chapter 11 bankruptcy protection [...]
San Francisco-based 23andMe, which sells at-home DNA testing kits, has filed for bankruptcy in the US and is looking for a new buyer — heightening concerns about the personal data of millions of peo [...]
Remember when Japan sent a spacecraft to an asteroid 180 million miles away to scoop some dirt off the surface? Six years on from its arrival to Earth, that sample has yielded some insights about what [...]